NASD · Healthcare · Health Information Services · USA
Schrodinger Inc is a small cap company (market value between $300 million and $2 billion) in the Health Information Services industry.
Schrodinger Inc offers a computational platform based on physics principles to help organizations discover new drug molecules and materials more efficiently. The company licenses its software to pharmaceutical firms, research institutions, and government agencies globally, while also developing its own therapeutic candidates and working with industry collaborators on molecular discovery projects.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Schrodinger Inc stock.
Overvalued: intrinsic value $7.24 per share, market price $25.66, margin of safety -254.3% (as of 2026-11-17).
A 1.0x revenue multiple, discounted for its losses, values the shares at $7.24; the price of $25.66 is 254% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 40 Health Information Services stocks
8 more in this industry show a wider margin of safety.
SDGR is overvalued (as of the 2026-11-17 close). A 1.0x revenue multiple, discounted for its losses, values the shares at $7.24; the price of $25.66 is 254% above that value.
$7.24 per share (as of the 2026-11-17 close), against a market price of $25.66. That is a margin of safety of -254.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.